Indivior Pharmaceuticals, Inc. [INDV] - Indivior Pharmaceuticals declares special dividend contingent on merger with Supernus Pharmaceuticals

Indivior Pharmaceuticals, Inc. announced a special cash dividend of $8.13 per share, payable to holders of record as of October 30, 2026, contingent upon the closing of its merger with Supernus Pharmaceuticals, Inc. expected on or about November 2, 2026.

View source filing ↗